Potential Injection of Human Umbilical Cord Secretome in the Case of Trophic Ulcers (Pre-post Intervention)

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

January 1, 2022

Study Completion Date

January 2, 2023

Conditions
CM-MSC ; Stem Cell ; Trophic Ulcer ; Leprosy ; Morbun Hansen; Secretom
Interventions
BIOLOGICAL

Secretome

The interventions given in this study were Conditioned Medium Wharton's Jelly-derived mesenchymal stem cells (CM-WJMSCs) as much as 0.1cc / 1cm intracutaneously with a flexpen device in the wound area every 2 weeks. The variables in this study were divided into two, namely the independent variable was the use of Conditioned Medium Wharton's Jelly-derived mesenchymal stem cells (CM-WJMSCs) were administered intracutaneously, and the dependent variables were wound healing and side effects caused by the interventions given. Wound healing or repair in this study was assessed from several variables, namely the presence of granulation tissue growth, reduced edema, reduced erythema and improvement in wound size both in terms of length, width, and area measured by using a standard ruler and digital photo.

Trial Locations (2)

15810

Sukma Clinic, Tangerang

79123

RS Alverno Singkawang, Singkawang

All Listed Sponsors
collaborator

Tarumanagara University

OTHER

lead

Yohanes Firmansyah, dr, MH, MM

OTHER

NCT05777213 - Potential Injection of Human Umbilical Cord Secretome in the Case of Trophic Ulcers (Pre-post Intervention) | Biotech Hunter | Biotech Hunter